FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of experimental medicine. Method lies in application of phenotropil, which is introduced to rats of Wistar line intraperitoneally 1 time per day in dose 25 mg/kg for 10 days.
EFFECT: method makes it possible to improve life quality in period of excessive intellectual stress, increase mental and physical workability, as well as resistance to extreme impacts.
4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MODELLING CHRONIC FATIGUE IN EXPERIMENT | 2010 |
|
RU2449379C1 |
| METHOD OF NEUROIMMUNE DISORDER CORRECTION IN EXPERIMENTAL IMMUNOPATHOLOGY | 2010 |
|
RU2429835C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| 9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
| 4-PHENYL PYRROLIDINONE-2 DERIVATIVE, NOOTROPIC COMPOSITION THEREOF, METHOD FOR PRODUCING THEREOF AND METHOD PREVENTIVE TREATMENT OF NERVOUS SYSTEM DISORDERS | 2015 |
|
RU2611623C2 |
| ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
| MEANS FOR CORRECTION OF PSYCHOEMOTICAL STATUS OF ORGANISM BASED ON ASTRAGALUS HERBS EXTRACT | 2016 |
|
RU2642595C1 |
| ANTIDEPRESSANT | 2012 |
|
RU2535027C2 |
| PHARMACEUTICAL COMPOSITION BASED ON N-BUTYL-N-METHYL-1-PHENYLPYRROLO[1,2-a]PYRAZINE-3-CARBOXAMIDE | 2023 |
|
RU2811453C1 |
| SUBSTANCE OF NEUROTROPIC- NEUROREGULATING ACTIVITY | 2006 |
|
RU2329804C2 |
